Site map

• About us
  • Environmental, social and governance strategy
  • Health regulations and standards
  • Our locations
  • Partnerships
    • Working with healthcare professionals
    • Working with pharmaceutical and biotech companies
    • Working with the NHS
  • Patient care and safety
• Careers
• Contact us
• Knowledge hub
• Leaders with purpose
• Meet us at the UK Oncology Forum 2024
• Meet us at the World Orphan Drug Congress 2024
• NHS biosimilar switching
• Partnership
• Patient enquiry
• Patient hub
  • Cancer companion app for patients
  • For cancer patients
  • New patients: where to start and what to expect
  • NHS patients
  • Private patients
  • Sciensus Intouch app
• Patient Resources
• Privacy notices
• Sciensus Digital+
  • Digital solutions
    • Online communities
    • Sciensus Connect
    • SciensusPRO
• Sciensus patient and carer representative
• Sciensus set to address patient support challenges in Europe at World Orphan Drug Congress 2024
• Services
  • Clinical trials
  • Drive increased adherence through holistic patient support programs
  • Leverage real-world data to drive brand success
  • Sciensus’ unique aseptic compounding pharmacy proposition
  • Virtual Wards
• Therapeutic areas
  • Cancer
    • Sciensus cancer care nurses
  • Long-term conditions
  • Rare Diseases and Orphan Drugs
    • Early access program (EAP) 
    • European drug approval pathway
    • Finding patients: Tailored strategies for better outcomes 
    • Healthcare products (via Sciensus Axcess)
    • Orphan drugs supply chain management
    • Our expanded access program services
      • Expanded access program (EAP) services
        • Expanded Access Programs – Thank you!
    • Regulatory approval consulting